LADW
LADW is a tetrapeptide derived from the hydrolysate of tuna skeletal muscle myosin, with dual inhibitory activities against angiotensin-converting enzyme 1 (ACE1) and α-glucosidase. The IC50 value of LADW against ACE1 is 28.02 μM, while its IC50 value against Saccharomyces cerevisiae α-glucosidase is 4.40 mM. LADW binds competitively to the active site of ACE1, stabilizes the enzyme conformation, and blocks substrate binding. LADW binds to α-glucosidase to inhibit carbohydrate hydrolysis and can also alter starch structure. LADW can be used in studies related to hypertension and diabetes.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C24H33N5O7
- 분자량:503.55
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
LADW forms strong interactions with eNOS, ECE-1 and Furin via hydrogen bonds and van der Waals forces and binds to the key active residues of these proteins according to molecular docking results[1].
LADW inhibits the hydrolysis of soluble starch during simulated gastrointestinal digestion by altering starch structure, reducing the production of reducing sugars by 39.56%[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:EA.hy926 vascular endothelial cells
-
Concentration:150 μM, 300 μM
-
Incubation Time:24 h
-
Result:Increased NO release by 45.88% (150 μM) and 78.94% (300 μM) compared to controls.
Reduced ET-1 secretion by 22.34% (150 μM) and 60.79% (300 μM) compared to controls.
Chemical Information
-
분자량 503.55
-
화학식 C24H33N5O7
-
Sequence
Leu-Ala-Asp-Trp
-
Sequence Shortening
LADW
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)